Minimally Invasive Surgical Techniques and Robotic Precision
Advanced healthcare at Sana Hospital is defined by procedures that achieve better outcomes with less patient trauma. The hospital’s robotic surgery program covers https://www.sanahospitalvnb.com/ urology, gynecology, colorectal, and thoracic procedures, using wristed instruments that bend and rotate far beyond human capability. For prostate cancer patients, robotic-assisted radical prostatectomy results in less blood loss, shorter catheter time, and faster return to urinary continence compared to open surgery. Similarly, single-incision laparoscopic cholecystectomies leave virtually no visible scar. All robotic surgeons undergo rigorous simulation training and proctoring, with 100 cases required before independent practice. The result is complication rates 60 percent lower than national averages for comparable procedures.
Precision Oncology and Molecular Profiling
Cancer treatment has moved beyond one-size-fits-all chemotherapy, and Sana Hospital’s oncology department leads in precision medicine. Every solid tumor biopsy undergoes next-generation sequencing to identify driver mutations such as EGFR, ALK, or BRAF. Patients then receive targeted therapies—pills that attack cancer cells with specific genetic abnormalities while sparing healthy tissue. For breast cancer patients, Oncotype DX testing predicts chemotherapy benefit with high accuracy, allowing many to safely avoid toxic drugs. Immunotherapy checkpoint inhibitors are offered for lung cancer and melanoma, with PD-L1 expression guiding patient selection. A molecular tumor board meets weekly to interpret complex genomic reports and recommend clinical trial options when standard therapies fail.
Interventional Cardiology and Structural Heart Procedures
Sana Hospital’s catheterization laboratory is equipped with biplane angiography, intravascular ultrasound, and fractional flow reserve technology for precise assessment of coronary blockages. Beyond standard stenting, interventional cardiologists perform transcatheter aortic valve replacement (TAVR) for patients too high-risk for open-heart surgery, using a femoral artery approach that requires only a small incision. For patients with atrial fibrillation, left atrial appendage closure devices reduce stroke risk without lifelong blood thinners. Chronic total occlusion angioplasty, one of the most challenging procedures in cardiology, is performed with antegrade and retrograde dissections, achieving success rates over 85 percent. These advanced techniques allow patients to return home within days rather than weeks.
Neurological Interventions and Stroke Care
Time is brain in stroke treatment, and Sana Hospital operates a Comprehensive Stroke Center with 24/7 interventional neurology coverage. For ischemic stroke patients, mechanical thrombectomy using stent retrievers can remove large-vessel clots up to 24 hours after symptom onset, based on advanced perfusion imaging. The hospital’s MRI and CT perfusion software identifies salvageable brain tissue, extending the treatment window beyond traditional limits. For hemorrhagic stroke, neurosurgeons perform minimally invasive endoscopic evacuation of intracerebral hemorrhages, reducing secondary brain injury. Deep brain stimulation is available for Parkinson’s patients who no longer respond adequately to medications, with intraoperative microelectrode recording ensuring precise lead placement. These advanced treatments have reduced stroke disability rates by 35 percent at 90 days.
Regenerative Medicine and Platelet-Rich Plasma Therapies
While still emerging, regenerative medicine at Sana Hospital offers new hope for orthopedic and wound care patients. Platelet-rich plasma injections, derived from the patient’s own blood, concentrate growth factors to accelerate healing of chronic tendinopathies like tennis elbow and Achilles tendinopathy. For diabetic foot ulcers unresponsive to standard care, amniotic membrane allografts provide extracellular matrix that stimulates new tissue growth, reducing amputation rates. The hospital’s research arm is currently recruiting for a clinical trial of autologous mesenchymal stem cells for knee osteoarthritis, with preliminary data showing pain reduction at six months. All regenerative treatments are performed under strict sterile protocols, and patients receive detailed education about evidence levels since these therapies remain a subject of ongoing study.
